» Articles » PMID: 22763950

Quantifying the Impact of Between-study Heterogeneity in Multivariate Meta-analyses

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2012 Jul 6
PMID 22763950
Citations 269
Authors
Affiliations
Soon will be listed here.
Abstract

Measures that quantify the impact of heterogeneity in univariate meta-analysis, including the very popular I(2) statistic, are now well established. Multivariate meta-analysis, where studies provide multiple outcomes that are pooled in a single analysis, is also becoming more commonly used. The question of how to quantify heterogeneity in the multivariate setting is therefore raised. It is the univariate R(2) statistic, the ratio of the variance of the estimated treatment effect under the random and fixed effects models, that generalises most naturally, so this statistic provides our basis. This statistic is then used to derive a multivariate analogue of I(2), which we call I(R)(2). We also provide a multivariate H(2) statistic, the ratio of a generalisation of Cochran's heterogeneity statistic and its associated degrees of freedom, with an accompanying generalisation of the usual I(2) statistic, I(H)(2). Our proposed heterogeneity statistics can be used alongside all the usual estimates and inferential procedures used in multivariate meta-analysis. We apply our methods to some real datasets and show how our statistics are equally appropriate in the context of multivariate meta-regression, where study level covariate effects are included in the model. Our heterogeneity statistics may be used when applying any procedure for fitting the multivariate random effects model.

Citing Articles

Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis.

Al Said S, Kaier K, Nury E, Alsaid D, Gibson C, Bax J Cochrane Database Syst Rev. 2025; 2:CD013745.

PMID: 39991882 PMC: 11848970. DOI: 10.1002/14651858.CD013745.pub2.


Safety and effectiveness of Salvia miltiorrhiza and ligustrazine injection for acute cerebral infarction in Chinese population: a PRISMA-compliant meta-analysis.

Ma Z, Zhang H, Zhao F, Li K, Dong N, Sang W Front Pharmacol. 2024; 15:1425053.

PMID: 39687295 PMC: 11646771. DOI: 10.3389/fphar.2024.1425053.


Different interventions to prevent preterm birth in pregnant women with cervical shortening during pregnancy: a protocol for a network meta-analysis.

Luo J, Liu D, Liu J BMJ Open. 2024; 14(11):e084015.

PMID: 39532349 PMC: 11574485. DOI: 10.1136/bmjopen-2024-084015.


Complications in Prolonged Intraoperative Ischemia Time in Free Flap Breast Reconstruction: A Systematic Review and Meta-Analysis.

Arellano J, Comerci A, Liu H, Alessandri Bonetti M, Nguyen V, Parent B Aesthetic Plast Surg. 2024; .

PMID: 39322841 DOI: 10.1007/s00266-024-04382-7.


Independent and joint associations of cardiometabolic multimorbidity and depression on cognitive function: findings from multi-regional cohorts and generalisation from community to clinic.

Zhao X, Xu X, Yan Y, Lipnicki D, Pang T, Crawford J Lancet Reg Health West Pac. 2024; 51:101198.

PMID: 39308753 PMC: 11416683. DOI: 10.1016/j.lanwpc.2024.101198.


References
1.
DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

2.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

3.
Jackson D, Riley R, White I . Multivariate meta-analysis: potential and promise. Stat Med. 2011; 30(20):2481-98. PMC: 3470931. DOI: 10.1002/sim.4172. View

4.
Biggerstaff B, Jackson D . The exact distribution of Cochran's heterogeneity statistic in one-way random effects meta-analysis. Stat Med. 2008; 27(29):6093-110. DOI: 10.1002/sim.3428. View

5.
Rucker G, Schwarzer G, Carpenter J, Schumacher M . Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008; 8:79. PMC: 2648991. DOI: 10.1186/1471-2288-8-79. View